Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott N. Boyle currently holds 10,500 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott N. Boyle has been a net neutral trader of CCCC stock. They have purchased $0 and sold $0 worth of shares.
Scott N. Boyle's most recent insider trade was on Nov 7, 2024, when they sold 3,750 shares at $0.00 per share.
Scott N. Boyle serves as Executive at C4 Therapeutics, Inc. (CCCC). They have executed 16 insider transactions totaling $0 over their tenure at the company.
Scott N. Boyle holds the position of Executive at C4 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Scott N. Boyle has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Scott N. Boyle was on Feb 13, 2024, when they sold $11.3K worth of CCCC shares. This transaction involved 1,735 shares at $6.53 per share.
Scott N. Boyle currently owns 10,500 shares of C4 Therapeutics, Inc. (CCCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott N. Boyle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott N. Boyle has 16 Form 4 filings on record as an insider at C4 Therapeutics, Inc..
Set alerts for Scott N. Boyle and 40,000+ other insiders.